News Hyphens Pharma International Limited

Equities

1J5

SG1EE4000006

Market Closed - Singapore S.E. Other stock markets 01:42:23 2024-04-24 am EDT			5-day change	1st Jan Change
0.275 ^SGD	0.00%		0.00%	-3.51%

Apr. 09	Hyphens Pharma’s Attributable Profit Narrows in 2023	MT
Apr. 09	Hyphens Pharma International Limited Proposes Final Tax Exempt (One-Tier) Dividend	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hyphens Pharma’s Attributable Profit Narrows in 2023	Apr. 09	MT
Hyphens Pharma International Limited Proposes Final Tax Exempt (One-Tier) Dividend	Apr. 08	CI
Hyphens Pharma Buys Back Shares	Apr. 02	MT
CGS-CIMB Adjusts Hyphens Pharma’s Price Target to SG$0.35 From SG$0.32, Keeps at Add	Mar. 15	MT
Hyphens Pharma licenses Wynzora Cream for ASEAN countries from MC2 Therapeutics	Mar. 13	AQ
MC2 Therapeutics Announces License, Supply and Commercialization Agreement for Wynzora Cream in ASEAN Countries	Mar. 13	AQ
Hyphens Pharma Obtains License to MC2's Psoriasis Cream	Mar. 13	MT
Hyphens Pharma International Limited Signs Exclusive Distribution Agreement with Cooper Pharma, S.A	Feb. 29	CI
Hyphens Pharma International Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Hyphens Pharma Strikes Distribution Deal With 7-Eleven Singapore	Feb. 13	MT
Hyphens Pharma Partners 7-Eleven to Offer Ocean Health Supplements in Singapore	Feb. 06	CI
Hyphens Pharma International Grants Nearly 6 Million Shares Under Performance Share Plan	Dec. 11	MT
CGS-CIMB Adjusts Hyphens Pharma’s Price Target to SG$0.32 From SG$0.34, Keeps at Add	Nov. 28	MT
Hyphens Pharma International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Hyphens Pharma Unit Completes Purchase of First Tranche of Remaining Ardence Pharma Stake	Nov. 08	MT
Hyphens Pharma to Acquire Remaining 58% Stake in Ardence Pharma	23-10-18	MT
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia	23-08-30	MT
Hyphens Pharma International Limited Announces Special Interim Tax Exempt (One-Tier) Dividend for the Financial Year Ending 31 December 2023, Paid on 31 August 2023	23-08-10	CI
Hyphens Pharma International Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-10	CI
Hyphens Pharma Names CFO	23-06-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hyphens Pharma International Limited

Equities

1J5

SG1EE4000006

Summary

Filters